Sign up
Quantellect · Congress · Trade Detail
NYSE: ELVElevance Health Inc
RepublicanSenate

John R. Curtis sold Elevance Health Inc (NYSE: ELV)

John R. Curtis (R-UT), a U.S. Senator, has disclosed 3 trades in Elevance Health Inc (ELV) since 2022, 1 purchase and 2 sales, worth an estimated $24K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: John R. Curtis sold $1,001 - $15,000 of Elevance Health Inc (NYSE: ELV) on December 20, 2022. Since that trade, ELV is down -21.56% against the S&P 500 up +99.96%, an outperformance of -121.53%.

Across these filings, John R. Curtis has been a net seller of ELV (a buy-to-sell ratio of 0.50). The most recent disclosed ELV transaction shown was dated December 4, 2023. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

ELV trades
3
Disclosed Vol
$24K
Buys
1
33%
Sells
2
67%
Buy / Sell
0.50
ratio
First → Last
2022–2023

John R. Curtis's ELV trades vs the price

ELV is down -21.56% since John R. Curtis sold on December 20, 2022, versus +99.96% for the S&P 500.

Performance since this trade

Price change since trade
-21.56%
S&P 500 change since trade
+99.96%
Outperformance vs S&P 500
-121.53%

All John R. Curtis ELV trades

TradedTypeSizeReturnEst. profit
December 4, 2023SELL$463.36-18.86%
April 26, 2023BUY$431.06-12.78%-$1K
December 20, 2022SELL$479.34-21.56%

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

John R. Curtis & ELV trading FAQ

Is it legal for John R. Curtis to trade Elevance Health Inc (ELV) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Elevance Health Inc (ELV), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did John R. Curtis sell ELV?

John R. Curtis disclosed a sale of $1,001 - $15,000 of Elevance Health Inc (ELV) on December 20, 2022, according to public STOCK Act filings.

How has ELV performed since John R. Curtis's trade?

Since John R. Curtis sold ELV on December 20, 2022, the stock is down -21.56%, versus +99.96% for the S&P 500 over the same period, an outperformance of -121.53%.

How many times has John R. Curtis traded ELV?

John R. Curtis has disclosed 3 ELV trades since 2022 (1 purchase and 2 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional ELV trades?

Quantellect tracks every disclosed congressional trade in Elevance Health Inc (ELV) on the Elevance Health Inc congressional trading page, which aggregates filings across all members of Congress.

John R. Curtis's ELV tradesAll congressional filings for Elevance Health IncJohn R. Curtis's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.